Which condition is NOT treated with Flunixin meglumine in cattle?

• A. Mastitis
• B. Endotoxemia
• C. Fever from respiratory disease
• D. Chronic arthritis

Answer: (D)

Flunixin meglumine is a non-steroidal anti-inflammatory drug (NSAID) commonly used in cattle for its analgesic, anti-inflammatory, and antipyretic properties. It is indicated for various conditions that involve pain, inflammation, or fever.

Mastitis, endotoxemia, and fever from respiratory disease are all situations where the anti-inflammatory and analgesic effects of flunixin meglumine can be beneficial. For instance, in mastitis, it helps reduce inflammation and pain associated with the infection. In cases of endotoxemia, the drug aids in controlling inflammation and pain due to systemic toxic reactions. Similarly, it is effective in treating fever associated with respiratory disease by lowering body temperature and alleviating discomfort.

On the other hand, chronic arthritis in cattle is typically more complex and may not respond adequately to flunixin meglumine alone. While it might provide temporary relief, the underlying causes of chronic arthritis often require more comprehensive management strategies, including long-term adjustments in treatment, rather than just an NSAID. Therefore, it is less appropriate to rely on flunixin meglumine as a primary treatment option for chronic arthritis.